Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis ...Middle East

OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions (incl. anaphylaxis) and is based on the proprietary AmorphOX® technology. The clinical study, OX640-002, evaluated both pharmacokinetic and pharmacodynamic effects of OX640 in subjects...

Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis )

Also on site :

• Mossad thanks CIA for help with Operation Rising Lion
• What to Know About the Investigation Into Influencer Gloria Zamora’s Death
• Egypt vows no power cuts this summer, cites gas supply boost